- $1.37bn
- $2.43bn
- $1.17bn
- 60
- 69
- 78
- 79
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 16.65 | ||
PEG Ratio (f) | 0.23 | ||
EPS Growth (f) | 275.28% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.46 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 16.47 | ||
Price to Sales | 1.17 | ||
EV to EBITDA | 10.39 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 2.74% | ||
Return on Equity | -2.06% | ||
Operating Margin | 5.13% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 613.07 | 773.31 | 1,038.69 | 1,121.29 | 1,174.6 | 1,223.83 | 1,288.2 | 15.75% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | +3.72 | n/a | n/a | +6.75 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Agiliti, Inc. is an essential service provider to the United States healthcare industry. The Company offers healthcare providers a comprehensive suite of medical equipment management and service solutions. The Company’s gateway solutions offer an entry point to the economic buyer and include peak needs equipment, surgical lasers and equipment, specialty beds and surfaces and supplemental clinical engineering services. Its vertical solutions include clinical offerings tailored to specific patient needs and clinical engineering programs for equipment categories. The Company provides comprehensive, connected solutions through onsite managed services and outsourced clinical engineering services. The Company also provides comprehensive logistics, management and clinical engineering solutions that allow IDNs to manage equipment inventories across multiple locations, and supports city, state and federal government agencies in managing and maintaining equipment stockpiles.
Directors
- John Workman NEC (69)
- Thomas Boehning PRE (55)
- Thomas Leonard CEO (53)
- James Pekarek CFO (52)
- Robert Creviston CHO (63)
- Lee Neumann SVP (45)
- David Anbari SVP
- Bettyann Bird SVP (61)
- Scott Christensen CAO (56)
- Matthew Mccabe VPR (40)
- Diane Patrick DRC (69)
- Michael Bell IND (65)
- Darren Friedman IND (52)
- Gary Gottlieb IND (65)
- Joshua Nelson IND (48)
- Megan Preiner IND (37)
- Scott Sperling IND (64)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 1st, 2018
- Public Since
- January 29th, 2019
- No. of Shareholders
- 11
- No. of Employees
- 5,800
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- New York Stock Exchange
- Shares in Issue
- 135,960,875
- Address
- 11095 Viking Drive, Suite 300, EDEN PRAIRIE, 55344
- Web
- https://investors.agilitihealth.com/
- Phone
- +1 9528933200
- Auditors
- KPMG LLP
Upcoming Events for AGTI
Agiliti Inc Annual Shareholders Meeting
Q2 2024 Agiliti Inc Earnings Release
Similar to AGTI
Abbott Laboratories
New York Stock Exchange
Agilent Technologies
New York Stock Exchange
Alcon AG
New York Stock Exchange
Artivion
New York Stock Exchange
Avanos Medical
New York Stock Exchange
FAQ
As of Today at 19:00 UTC, shares in Agiliti are trading at $10.10. This share price information is delayed by 15 minutes.
Shares in Agiliti last closed at $10.10 and the price had moved by -35.5% over the past 365 days. In terms of relative price strength the Agiliti share price has underperformed the S&P500 Index by -47.98% over the past year.
The overall consensus recommendation for Agiliti is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAgiliti does not currently pay a dividend.
Agiliti does not currently pay a dividend.
Agiliti does not currently pay a dividend.
To buy shares in Agiliti you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $10.10, shares in Agiliti had a market capitalisation of $1.37bn.
Here are the trading details for Agiliti:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: AGTI
Based on an overall assessment of its quality, value and momentum Agiliti is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Agiliti is $10.00. That is 0.99% below the last closing price of $10.10.
Analysts covering Agiliti currently have a consensus Earnings Per Share (EPS) forecast of $0.59 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Agiliti. Over the past six months, its share price has outperformed the S&P500 Index by +43.09%.
As of the last closing price of $10.10, shares in Agiliti were trading +14.98% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Agiliti PE ratio based on its reported earnings over the past 12 months is 16.65. The shares last closed at $10.10.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Agiliti's management team is headed by:
- John Workman - NEC
- Thomas Boehning - PRE
- Thomas Leonard - CEO
- James Pekarek - CFO
- Robert Creviston - CHO
- Lee Neumann - SVP
- David Anbari - SVP
- Bettyann Bird - SVP
- Scott Christensen - CAO
- Matthew Mccabe - VPR
- Diane Patrick - DRC
- Michael Bell - IND
- Darren Friedman - IND
- Gary Gottlieb - IND
- Joshua Nelson - IND
- Megan Preiner - IND
- Scott Sperling - IND